• India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
More
Hindi Tamil Telugu
More
In the news
Narendra Modi
Amit Shah
Box Office Collection
Bharatiya Janata Party (BJP)
OTT releases
Hindi Tamil Telugu
User Placeholder

Hi,

Logout

India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
Home / News / Technology News / #VaccineTracker: Early COVID-19 vaccine results expected by September 15
Next Article
#VaccineTracker: Early COVID-19 vaccine results expected by September 15

#VaccineTracker: Early COVID-19 vaccine results expected by September 15

By Shubham Sharma
Sep 04, 2020
03:24 pm

What's the story

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

The companies working on the shots have maintained that they expect to have them ready by the end of this year, but it depends on the final data, part of which will be published this month.

Here are more details.

Front-runners

Over 170 vaccine candidates developed so far

Ever since the pandemic began, leading institutes and pharma companies have been racing to develop a vaccine.

Their efforts have led to the development of more than 170 candidates, of which 34 are moving through different stages of human trials around the world.

These studies, conducted on thousands of people in three phases, are aimed at providing data on the candidates' safety and efficacy.

You're
16%
through

First result

Results from front-runners likely to be published first

Out of the 34 candidates in human trials, a select few are in the large-scale third phase - the last hurdle before regulatory approvals.

From this group, UK-based AstraZeneca is expected to be the first one to publish early results on whether their shot can prevent COVID-19 infection.

As per Airfinity Ltd., an analytics company tracking drug trials, their data could come by mid-September.

You're
33%
through

Second, Third

Moderna, Pfizer expected to follow next

After AstraZeneca, US giants Moderna and Pfizer could be sharing their late-stage trial results.

Their data, according to Airfinity, could come before October 22, which is when the Food and Drug Administration plans to have a key meeting over COVID-19 vaccines.

To note, Moderna was the first American company to get started with the human trials of a COVID-19 vaccine.

You're
50%
through

Fourth

Sinovac could be the fourth candidate to publish data

The fourth company to publish human trial data could be China's Sinovac Biotech.

Airfinity came to these estimates on the basis of the publicly available data on each of these companies' trial enrollment and design as well as the rate of infections where the participants have been enrolled.

If the rate of infection is high, the chances of gathering efficacy data sooner automatically increase.

You're
66%
through

Indication

This data will be a good indicator

Having said that, it must be noted that this data will just be an indicator of vaccine efficacy rather than giving a complete picture.

The full data for the three front-runners should be available by the end of this year, Airfinity noted.

However, in the case of the US, if the September-October results are good enough, the vaccines could be given early emergency-use approval.

You're
83%
through

India

When Indians can expect a vaccine?

In India, the internationally leading shot developed by Oxford University and AstraZeneca is being tested and manufactured locally by Serum Institute of India and should become available by the end of this year.

After that, homegrown candidates from Bharat Biotech and Zydus Cadila might follow up (if successful in ongoing human trials), providing a more affordable way to exit the pandemic.

Done!
Facebook
Whatsapp
Twitter
Linkedin
Related News
Latest
Pfizer
United States of America
COVID-19
AstraZeneca

Latest

Are Aamir and Rajamouli both making Phalke biopics?  Aamir Khan
Why was Usher named during Diddy's abuse trial? Hollywood
WHO members approve treaty to improve pandemic preparedness  COVID-19
UK, France, Canada threaten sanctions if Israel continues Gaza offensive  Benjamin Netanyahu

Pfizer

As Pfizer's Viagra patent ends, Indian firms prepare for dominance United States of America
As coronavirus pandemic surges, some vaccine makers expect to profit Vaccine
Pfizer's COVID-19 vaccine shows promise in human trials: Details here Vaccine

United States of America

'Inception' re-release enthralls UK and Ireland, earns over $200K Christopher Nolan
QAnon: What is it and how did it originate? X
Kamala Harris formally accepts Vice-Presidential nomination, rips into Trump's tenure Donald Trump
NewsBytes Briefing: Apple becomes a $2 trillion company, and more BlackBerry

COVID-19

Novavax's COVID-19 vaccine goes into mid-stage human trials: Details here South Africa
Amid COVID-19, YouTuber makes 'mask gun' to take on anti-maskers YouTuber
Amit Shah, who recovered from COVID-19, admitted to AIIMS All India Institute Of Medical Sciences (AIIMS)
Indian government starts talks to procure COVID-19 vaccine: Details here India

AstraZeneca

COVID-19 vaccine: What are the latest updates? Oxford
#GoodNews: Oxford's COVID-19 vaccine may be available by September-end Oxford
Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India Oxford University
Coronavirus: How much would the vaccines cost? Moderna Inc
Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin
All rights reserved © NewsBytes 2025